Skip to main content
. 2017 Sep 20;7:12008. doi: 10.1038/s41598-017-11883-w

Table 1.

Demographic and clinical characteristics of participants.

ASD (n = 134) Control (n = 160) Chi-2/t-test
Mean age (SD) 28 (10) 30 (11) Student t-test; p = 0.2
Sex; Men (%) 117 (87) 133 (83) Chi-2; p = 0.5
Site Créteil (n = 40) Créteil (n = 58)
NYU1 (n = 12) NYU1 (n = 23)
USM2 (n = 33) USM2 (n = 21)
CAL3 (n = 13) CAL3 (n = 15)
BNI4 (n = 22) BNI4 (n = 25)
IU5 (n = 14) IU5 (n = 18)
Mean ADOS scores (SD) 12,3 (4)*
Mean full scale IQ (SD) 104 (16)** N/A

1NYU, New York University, ABIDE I sample.

2USM, University of Santa Monica, ABIDE I sample.

3CAL, California Institute of Technology, ABIDE I sample.

4BNI, Barrow Neurological Institute, ABIDE II sample.

5IU, Indiana University, ABIDE II sample.

N/A: not available.

40 individuals with ASD and 58 controls were included in the global segmentation analysis. After quality-check, 37 individuals with ASD and 56 controls were included in the anterior lobe analysis; 37 individuals with ASD and and 58 controls were included in the Crus I/Vermis analysis. In the eye-tracking analysis, 33 indviduals with ASD and 26 controls were included (See Supplementary Material 2 for full Table).

*Data for BNI missing (different versions of the ADOS scores (total of communication and social interaction subscores) that could not be computed in the same mean).

**Data missing for 31 individuals with ASD (but global IQ > 70) or IQ > 85 (−1 DS) assessed with the Kaufman Brief Intelligence Test-2 (KBIT2) in the BNI center and the National Adult Reading Test (NART) in Créteil (France).